Chang‐Chun Ling
- Topics
- Nanoplatforms for cancer theranostics (8 papers)Histone Deacetylase Inhibitors Research (4 papers)Synthesis and bioactivity of alkaloids (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Chang‐Chun Ling
23 papers receiving 527 citations
Peers
Comparison fields: 5 of 72
- Molecular Biology 235
- Surgery 131
- Biomedical Engineering 108
- Cancer Research 96
- Biomaterials 90
Countries citing papers authored by Chang‐Chun Ling
This map shows the geographic impact of Chang‐Chun Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Chun Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Chun Ling more than expected).
Fields of papers citing papers by Chang‐Chun Ling
This network shows the impact of papers produced by Chang‐Chun Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Chun Ling. The network helps show where Chang‐Chun Ling may publish in the future.
Co-authorship network of co-authors of Chang‐Chun Ling
This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Chun Ling. A scholar is included among the top collaborators of Chang‐Chun Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Chun Ling. Chang‐Chun Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 5 | |
| 4 | 4 | |
| 5 | 6 | |
| 6 | 18 | |
| 7 | 85 | |
| 8 | 23 | |
| 9 | 11 | |
| 10 | 34 | |
| 11 | 8 | |
| 12 | 8 | |
| 13 | 39 | |
| 14 | 36 | |
| 15 | 26 | |
| 16 | 40 | |
| 17 | 79 | |
| 18 | 12 | |
| 19 | 0 | |
| 20 | 7 |
About Chang‐Chun Ling
Chang‐Chun Ling is a scholar working on Cancer Research, Biomaterials and Toxicology, having authored 24 papers that have together received 530 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Histone Deacetylase Inhibitors Research (4 papers) and Synthesis and bioactivity of alkaloids (2 papers). The work is most often cited by research in Biomaterials (90 citations), Cancer Research (96 citations) and Hepatology (48 citations). Chang‐Chun Ling has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yong Ling, Chi Meng, Jianqiang Qian, Weijie Gao, Kwan Man, Yan Huang, Mingyan Zhu, Yibing Guo, Xiangjun Fan and Changxian Li. Their work appears in journals such as Journal of Hepatology, Magnetic Resonance in Medicine and Analytica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.